VRTX - VERTEX PHARMACEUTICALS INC / MA

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 416.81

Open

$ 407.36

Bid

$ 410.00 x 2

Ask

$ 418.79 x 1

Day's Range

$ 406.76 - $ 419.37

52 Week Range

$ 362.50 - $ 519.88

Volume

1,054,386

Average Volume

Market Cap

106.87B

Beta (5Y Monthly)

$ 0.54

PE Ratio (TTM)

$ 29.38

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-06-2025	03-31-2025	10-Q
3	02-13-2025	12-31-2024	10-K
4	11-05-2024	09-30-2024	10-Q
5	08-02-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-15-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-02-2023	06-30-2023	10-Q
10	05-02-2023	03-31-2023	10-Q
11	02-10-2023	12-31-2022	10-K
12	10-28-2022	09-30-2022	10-Q
13	08-05-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	02-09-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	07-30-2021	06-30-2021	10-Q
18	04-30-2021	03-31-2021	10-Q
19	02-11-2021	12-31-2020	10-K
20	10-30-2020	09-30-2020	10-Q
21	07-31-2020	06-30-2020	10-Q
22	05-01-2020	03-31-2020	10-Q
23	02-13-2020	12-31-2019	10-K
24	10-31-2019	09-30-2019	10-Q
25	08-01-2019	06-30-2019	10-Q
26	05-01-2019	03-31-2019	10-Q
27	02-13-2019	12-31-2018	10-K
28	10-25-2018	09-30-2018	10-Q
29	07-26-2018	06-30-2018	10-Q
30	04-27-2018	03-31-2018	10-Q
31	02-15-2018	12-31-2017	10-K
32	10-30-2017	09-30-2017	10-Q
33	07-28-2017	06-30-2017	10-Q
34	04-28-2017	03-31-2017	10-Q
35	02-23-2017	12-31-2016	10-K
36	10-31-2016	09-30-2016	10-Q
37	08-01-2016	06-30-2016	10-Q
38	05-03-2016	03-31-2016	10-Q
39	02-16-2016	12-31-2015	10-K
40	10-30-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Earlier: Vertex Advances Povetaci...
10/17/2025 15:34:58

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vert...

vera-therapeutics-lead-kidney-drug-poised-for-2026-launch-in-multi-billion-dollar-market

Vera Therapeutics' Lead Kidney Drug Poised...
10/16/2025 18:17:37

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

Here's How Much $100 Invested In Vertex Ph...
10/14/2025 14:15:20

Morgan Stanley Maintains Equal-Weight on V...
10/10/2025 17:32:10

Morgan Stanley analyst Terence Flynn maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and lowers the price...

Spotlight on Vertex Pharmaceuticals: Analy...
10/08/2025 18:01:11

JP Morgan Maintains Overweight on Vertex P...
10/08/2025 17:47:34

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target f...

Here's How Much You Would Have Made Owning...
10/06/2025 16:15:22

servicenow-vertex-pharmaceuticals-and-more-cnbcs-final-trades

ServiceNow, Vertex Pharmaceuticals And Mor...
10/03/2025 12:23:13

Jason Snipe likes ServiceNow (NOW), down 14% YTD. Morgan Stanley upgraded to Overweight. Shannon Saccocia chose iShares Core S&...

apple-to-rally-around-17-here-are-10-top-analyst-forecasts-for-thursday

Apple To Rally Around 17%? Here Are 10 Top...
10/02/2025 18:48:46

Citigroup Maintains Buy on Vertex Pharmace...
10/02/2025 17:43:13

Citigroup analyst Geoff Meacham maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $...

CNBC Halftime Report Final Trades: Service...
10/02/2025 17:00:51

10 Health Care Stocks Whale Activity In To...
10/01/2025 17:35:33

What Does the Market Think About Vertex Ph...
09/30/2025 15:00:40

10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

trumps-100-pharmaceutical-tariff-the-270-billion-manufacturing-war-that-could-reshape-your-medicine-cabinet

Trump's 100% Pharmaceutical Tariff: The $2...
09/26/2025 12:01:51

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creatin...

crowdstrike-to-rally-around-26-here-are-10-top-analyst-forecasts-for-thursday

CrowdStrike To Rally Around 26%? Here Are ...
09/25/2025 12:16:13

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Assessing Vertex Pharmaceuticals: Insights...
09/25/2025 12:01:13

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of bu...

Vertex Secures FDA Breakthrough For Poveta...
09/25/2025 11:49:03

- Food and Drug Administration granted Breakthrough Therapy Designation for povetacicept in IgA nephropathy; on track to file f...

this-chewy-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday

This Chewy Analyst Turns Bullish; Here Are...
09/25/2025 11:26:38

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Leerink Partners Upgrades Vertex Pharmaceu...
09/25/2025 10:54:19

Leerink Partners analyst David Risinger upgrades Vertex Pharmaceuticals (NASDAQ: VRTX) from Market Perform to Outperform and...